OVID
Ovid Therapeutics Inc.
$1.39
+$0.02(+1.46%)
52
Overall
60
Value
58
Tech
39
Quality
Market Cap
$105.95M
Volume
1.70M
52W Range
$0.24 - $2.01
Target Price
$4.50
EPS Estimates Overview
| Current Quarter | $-0.15 | Next Quarter | $-0.09 |
| Current Year | $-0.44 | Next Year | $-0.41 |
| QoQ Growth | +40.0% | YoY Growth | +6.8% |
| 3Y EPS CAGR | -30.2% | Target Price | $4.50 |
| Consensus | Buy | Upside | +223.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OVID | $1.39 | +1.5% | 1.70M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |